The Cancer Letter

Inside information on cancer research and drug development

Vol.
25
No.
36
September 24, 1999Sep 24, 1999
Free
DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

Roferon A Application Marred By Mission Data, Protocol, Compliance

Underpowered Study Of Evacet Dashes Approval Hopes

NCI Programs: Institute Funds 24 DNA Microarray Centers

Login

Site license subscribers:
Log in with your IP | Register a sponsored account